Disseminated superficial porokeratosis: rapid therapeutic response to 5-fluorouracil
Shelley, W.B.; Shelley, E.D.
Cutis 32(2): 139-140
1983
ISSN/ISBN: 0011-4162 PMID: 6617251 Document Number: 200999
Document emailed within 1 workday
Related Documents
Gutschmidt, E. 1977: Disseminated superficial actinic porokeratosis Zeitschrift für Hautkrankheiten 52(11): 622-624Kariniemi, A.L.; Kotovirta, M.L.; Stubb, S. 1979: Disseminated superficial "actinic" porokeratosis Acta Dermato-Venereologica 59(1): 82-84
Romanenko, V.N.; Protsenko, T.V. 1988: Disseminated superficial actinic porokeratosis Vestnik Dermatologii i Venerologii 3: 39-41
Vitetta, A.; Lacour, J.P. 1988: A case for diagnosis: disseminated superficial actinic porokeratosis Annales de Dermatologie et de Venereologie 115(6-7): 737-738
Klapholz, L.; Goldenhersh, M.; Sherman, Y.; Leibovici, V. 1991: Superficial actinic porokeratosis and cystic fibrosis Acta Dermato-Venereologica 71(5): 440-441
Sharma, R.C.; Mendiratta, V. 2001: Porokeratosis of mibelli: Disseminated non actinic form Indian Journal of Dermatology Venereology and Leprology 67(3): 158-159
Valcuende Cavero, F.; Ramírez Bosca, A.; Martínez Ojeda, L.; Torres Peris, V.; Castells Rodellas, A. 1989: Palmoplantar and disseminated porokeratosis: immunohistochemical study Medicina Cutanea Ibero-Latino-Americana 17(5): 277-281
D'souza, P.; Dhali, T.K.; Arora, S.; Gupta, H.; Khanna, U. 2014: Porokeratosis ptychotropica: a rare variant of porokeratosis Dermatology Online Journal 20(6)
Apel, H.P.; Kuhlwein, A.; Jänner, M. 1986: Porokeratosis linearis unilateralis (linear porokeratosis) Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 37(5): 284-286
Venkatarajan, S.; LeLeux, T.M.; Yang, D.; Rosen, T.; Orengo, I. 2010: Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil Dermatology Online Journal 16(12): 10
Moertel, C.G.; Schutt, A.J.; Reitemeier, R.J.; Hahn, R.G. 1972: A comparison of 5-fluorouracil administered by slow infusion and rapid injection Cancer Research 32(12): 2717-2719
Huang, W.Tsung.; Chang, K.Chao.; Shan, Y.Shen.; Tsao, C.Jung.; Lee, J.Chang. 2005: Successful initial treatment with weekly 24-hour infusion of 5-fluorouracil and leucovorin in a rectal cancer patient with acute disseminated intravascular coagulation Hepato-Gastroenterology 52(65): 1436-1439
Mills, E.J.; Ford, N. 2012: Political lessons from the global HIV/AIDS response to inform a rapid noncommunicable disease response Aids 26(9): 1171-1173
Oztop, I.; Demirkan, B.; Yaren, A.; Tarhan, O.; Sengul, B.; Ulukus, C.; Akin, D.; Sen, M.; Yilmaz, U.; Alakavuklar, M. 2004: Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan Tumori 90(5): 514-516
Griffith, M.L.; Flowers, F.P.; Araujo, O.E. 1986: Superficial mycoses. Therapeutic agents and clinical applications Postgraduate Medicine 79(1): 151-6 161
Chatelain, C. 1984: What therapeutic approach should be adopted for superficial bladder tumours? Progress in Clinical and Biological Research 162b: 211-218
Müller, H.; Nakchbandi, V.; Chatzisavvidis, I.; von Voigt, C. 2003: Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases Hepato-Gastroenterology 50(54): 1919-1926
Maughan, C.; Lear, W. 2013: Acute angioedema response to topical 5-fluorouracil therapy Dermatology Online Journal 19(3): 13
Boyer, J.; Maxwell, P.J.; Longley, D.B.; Johnston, P.G. 2004: 5-Fluorouracil: identification of novel downstream mediators of tumour response Anticancer Research 24(2a): 417-423
Athlin, L.; Domellöf, L. 1987: Response of human monocyte phagocytosis to FAM (fluorouracil, adriamycin, mitomycin) Acta Chirurgica Scandinavica 153(4): 279-281